Article may be outdated

This article is 10 days old. Some details may have changed since publication.

NPR News·3 min read·medium

A promising new medicine against heart disease fails unexpectedly

R
Rob Stein
A promising new medicine against heart disease fails unexpectedly
✦AI Summary

An experimental drug called pelacarsen failed to reduce heart attack and stroke risks in a major clinical trial, despite successfully lowering levels of the protein Lp(a). Researchers expressed disappointment as the drug did not provide the expected health benefits for patients with cardiovascular disease.

Why it matters

Cardiovascular disease remains the leading cause of death globally, and this failure highlights the ongoing difficulty in finding effective treatments for patients who already manage traditional risk factors.

✦Dive DeeperCreate a free account to unlock

Planet Flem/Digital Vision Vectors//Getty Images For stories on the science of healthy living, subscribe to NPR's Health newsletter.

An experimental drug doctors hoped would be the next big advance in preventing heart attacks and strokes failed a crucial test, researchers reported Saturday.

Living Better Heart disease deaths declined. And here's how to reduce your risk of the #1 killer The medicine, which reduces levels of a particle in the blood associated with heart attacks and strokes, didn't protect volunteers in a closely watched study.

"I was shocked. I had high hopes for success," says Steven Nissen , a cardiologist at the Cleveland Clinic who led the study. "Cardiovascular disease is still the leading cause of death in developed countries. And so we really were hoping to find additional therapies that would reduce risk."

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in